The Disruptive Technology Solutions for Cell and Gene Therapy Challenge program will unify the value chain for engineered cell and gene therapies across the continuum from discovery to commercialization.
Through collaborative partnerships with key stakeholders, it will advance a unique initiative to bring disruptive solutions to the design, development and delivery of cell and gene therapy to patients in Canada.
The NRC's unique CAR T-cell therapy
Learn more about how the NRC is working to develop cutting-edge, made-in-Canada CAR T-cell therapies.
About the program
Hosted via the NRC's Human Health Therapeutics Research Centre, the Disruptive Technology Solutions for Cell and Gene Therapy Challenge program will design and develop disruptive technology solutions for precision-engineered cell and gene therapies for the treatment and potential cure of chronic diseases and rare genetic disorders affecting Canadians.
In doing so, the NRC will coordinate a national effort to increase the affordability and accessibility of these ground-breaking technologies—in collaboration with academic facilities, research centres and networks, clinicians, hospital centres and others—to enable a national ecosystem for health innovation in the area of cell and gene therapies.
Learn more - About the Disruptive Technology Solutions for Cell and Gene Therapy Challenge program
Getting involved
The Disruptive Technology Solutions for Cell and Gene Therapy Challenge program invites stakeholders to express their interest in collaborating with NRC researchers on this program. Find out more about collaborating with us and how to apply to currently active opportunities; contribution funding is available to defray the research costs of eligible collaborators.
News
The latest information on news and events related to the NRC's Disruptive Technology Solutions for Cell and Gene Therapy Challenge program will be posted here as they become available.
Subscribe here!
Subscribe here to find out about new opportunities as they become available.
Contact us
If you are interested in collaborating with us, making investments in this area, or if you have any questions, please contact:
Risini Weeratna
Program Director, Disruptive Technology Solutions for Cell and Gene Therapy
Telephone: 613-990-7934
Email: NRC.healthprogram-programmesanté.CNRC@nrc-cnrc.gc.ca
Related links
- Challenge Programs
- Grant and contribution funding
- Funded collaborative R&D projects
- Human Health Therapeutics Research Centre
- Medical Devices Research Centre
- Digital Technologies Research Centre
- Security and Disruptive Technologies Research Centre
- Nanotechnology Research Centre
- Aquatic and Crop Resource Development Research Centre
- Metrology Research Centre
- Artificial Intelligence for Design Challenge program
- Made-in-Canada cancer therapy offers patients new hope